Croma-Pharma

Executive Summary

Croma-Pharma is a privately held, family-owned Austrian company established in 1976, specializing in minimally invasive aesthetic products for ophthalmology and dermatology. With a global footprint, the company offers a comprehensive portfolio of medical devices and injectables tailored for healthcare professionals. Its commitment to practitioner education is exemplified by the cromacare program, which supports advancements in aesthetic and regenerative medicine. As a niche player with a long-standing history, Croma-Pharma continues to innovate within its core therapeutic areas, leveraging its expertise to address evolving clinical needs and maintain a competitive edge in the aesthetic market.

Upcoming Catalysts (preview)

• Q2 2026Launch of new dermal filler line in European markets70% success
• Q4 2026Regulatory approval for ophthalmic device in Asia-Pacific60% success
• Q3 2026Expansion of cromacare educational program into North America80% success